glp-1 regulatory news 🚨 Big for people with type 1 diabetes who are using or are interested in using a GLP-1! 35 new recommendations have been published for use of GLP-1s and GLP-1/GIP in GLP-1 Pipeline Update: May 2026

Walking, swimming, strength training, or group classes all work

Patients taking semaglutide GLP-1 must be closely monitored by their medical provider for any potential side effects such as nausea, diarrhea, or hypoglycemia

2008 to 2017 Skin-whitening and skin-condition-improving effects of topical oxidized glutathione: a double-blind and placebo-controlled clinical trial in healthy women Clinical, Cosmetic and Investigational Dermatology: 2014

The objective of this review is to summarize the main renal outcomes from clinical studies while providing practical guidance on the use of GLP-1 RAs

Patients should note the date and time of application to maintain an accurate schedule